RecruitingNCT06967857
Two dexamfetamine formulations in adults with ADHD and depression
About this title
Read the official source — NCT06967857Medication studyAges 18–65Germany
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Adults with ADHD (attention deficit hyperactivity disorder) and moderate-to-severe depression are assigned to immediate-release dexamfetamine tablets twice daily, extended-release dexamfetamine once daily, or placebo (an inactive comparison treatment). The study examines safety and effectiveness; the registry entry reviewed does not specify the treatment period or visit schedule.
- Listed locations
- Berlin and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 15, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 105
- Sponsor
- Prof. Dr. Frank Behrens
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06967857
- Official title
Show the full official title
Randomized, Placebo-controlled Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression (DEXAD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Berlin · Bonn · Frankfurt
2 more locations
- Leipzig
- München
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Prof. Dr. Frank Behrens.
Does this study involve medication?
Yes. The study involves medication, including DEX IR tablets, DEX XL and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
